Physician profile
Samina Anwar
NPI 1902880560
$3,415.13
in general payments reported to CMS, 2019-2025
33 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $100 · 2021: $92.37 · 2022: $34.00 · 2023: $469 · 2024: $1,103 · 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,720 · Education: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,719.96 |
| Education | $328.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $400.15 | 2023-2025 | Ultomiris, Soliris |
| Pfizer INC. | $329.63 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $268.62 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $264.14 | 2019-2025 | |
| Abbvie INC. | $241.22 | 2023-2025 | Qulipta, Ubrelvy |
| Amgen INC. | $230.47 | 2024-2025 | Uplizna |
| Lundbeck LLC | $140.24 | 2024-2025 | Vyepti |
| Livanova USA, INC. | $135.14 | 2020-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Amneal Pharmaceuticals LLC | $123.21 | 2023-2025 | Rytary, Ongentys, Ongentys 50mg Capsules 30 |
| Argenx US, INC. | $115.11 | 2024-2025 | Vyvgart Hytrulo |
| Biogen, INC. | $99.68 | 2023-2025 | Vumerity, Avonex, Tysabri |
| Vanda Pharmaceuticals INC. | $92.61 | 2024-2025 | Ponvory |
| Neurocrine Biosciences, INC. | $90.61 | 2024-2025 | Ingrezza |
| Neurelis, INC. | $88.72 | 2024-2025 | Valtoco |
| Lilly USA, LLC | $78.66 | 2023-2024 | Emgality, Reyvow |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $78.53 | 2024-2025 | Ocrevus Zunovo |
| Tg Therapeutics, INC. | $76.59 | 2024-2025 | |
| Sunovion Pharmaceuticals INC. | $64.03 | 2020-2021 | |
| Horizon Therapeutics Plc | $63.48 | 2022-2023 | Uplizna |
| Medtronic USA, INC. | $63.33 | 2019-2020 | |
| Eisai INC. | $54.51 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $50.87 | 2024 | |
| Medtronic, INC. | $40.69 | 2024-2025 | Percept PC Brainsense, Inceptiv |
| Emd Serono, INC. | $30.85 | 2019 | |
| Springworks Therapeutics, INC. | $28.25 | 2025 | Gomekli |
| Sk Life Science, INC. | $28.17 | 2024 | |
| Ucb, INC. | $27.61 | 2025 | Rystiggo |
| Banner Life Sciences, LLC | $23.23 | 2024 | |
| Abbott Laboratories | $18.52 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.40 | 2020 | |
| Supernus Pharmaceuticals, INC. | $17.66 | 2020 | |
| Acorda Therapeutics, INC | $16.26 | 2019 | |
| Life Molecular Imaging LTD | $15.94 | 2025 | Neuraceq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samina Anwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.